Immunohistochemical Evaluation of Perlecan (Heparan Sulphate Proteoglycan 2) Expression in Invasive Female Breast Carcinoma

CONCLUSION: Perlecan expression measured by immunohistochemical staining is associated with aggressive characteristics in breast cancer, suggesting that Perlecan may help in cancer progression and can be investigated as a possible target therapy.PMID:38156864 | DOI:10.31557/APJCP.2023.24.12.4277

Source: Asian Pacific Journal of Cancer Prevention - December 29, 2023 Category: Cancer & Oncology Authors: Samar Ibrahim Amer Ismail Engy Talaat Helmy Ahmed Mahmoud Abdel Aziz Passant Essam Eldin Shibel Source Type: research